John Flavin, Portal Innovations CEO

Por­tal In­no­va­tions takes its Chica­go biotech in­vest­ing, lab space mod­el to Boston with Bob Langer start­up in tow

Life sci­ences in­vestor and lab op­er­a­tor Por­tal In­no­va­tions is tak­ing the blue­print it set in Chica­go and ex­pand­ing to Mass­a­chu­setts, where it will de­ploy $25 mil­lion, and help house new star­tups in the for­mer Boston Globe head­quar­ters.

Por­tal CEO and founder John Flavin told End­points News the com­pa­ny will open its Boston-area op­er­a­tions in the com­ing weeks, and its first lab oc­cu­pant will be Syn­tis Bio, an ear­ly-stage biotech out of Mod­er­na co-founder Bob Langer, MIT pro­fes­sor Gio­van­ni Tra­ver­so and Sher­lock Bio­sciences co-founder Rahul Dhan­da.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.